Opioid Crisis Accountability Act of 2018
Latest action · Apr 17, 2018 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 17, 2018
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Opioid Crisis Accountability Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks.
The bill penalizes drug manufacturers or distributors who illegally advertise, market or distribute an opioid product, including by (1) imposing a civil fine or salary confiscation, (2) revoking any remaining period of market exclusivity for such product, (3) requiring reimbursement of federal funding received for such product, and (4) prohibiting certain tax credits.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Apr 17, 2018 to Apr 19, 2018, with 1 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Kamala D. Harris | Original | Apr 17, 2018 |
| D-NY | Kirsten E. Gillibrand | Apr 19, 2018 | |
| D-CT | Richard Blumenthal | Apr 19, 2018 |
Actions 2
Everything that happened, newest first.
- Apr 17, 2018Introduced in Senate
- Apr 17, 2018Read twice and referred to the Committee on Finance.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 5782 | Opioid Crisis Accountability Act of 2018 | Identical bill | May 31, 2018 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Business ethics
- Business expenses
- Business records
- Child health
- Civil actions and liability
- Corporate finance and management
- Department of Health and Human Services
- Department of Justice
- Department of Labor
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Education programs funding
- Elementary and secondary education
- Employment taxes
- Executive agency funding and structure
- Government information and archives
- Government studies and investigations
- Government trust funds
- Health
- Health programs administration and funding
- Health promotion and preventive care
- Income tax credits
- Marketing and advertising
- Medical research
- Preschool education
- Prescription drugs
- Research and development
- Securities
- Small business
- Wages and earnings
Text 1
Each version as it was printed, newest first.
- Apr 17, 2018Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.